SlimQuick Extra Strength
SlimQuick Extra Strength, licence 80065569: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Slimquick
- NPN or DIN-HM
- 80065569
- Status
- Inactive licence
- Licence date
- 27 November 2015
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine D: up to 25.02 µg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Vitex agnus-castus L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Camellia sinensis Source : Camellia sinensis - feuille Extract : Matériel brut sec Extraction ratio : 12:1 Dry plant equivalent : 600 mg Potency : 9.5 mg Catechins | 50.0 mg | Not calculated |
| Camellia sinensis Source : Camellia sinensis - feuille Potency : 6.5 mg Epigallocatechin 3-gallate | Not specified | Not calculated |
| Camellia sinensis Source : Camellia sinensis - feuille Potency : 0.0 mg Caffeine | Not specified | Not calculated |
| Zingiber officinale Source : Zingiber officinale - racine | 2.0 mg | Not calculated |
| Iode Source : Iodure de potassium | 25.0 mcg | 150 µg |
| Bacopa monnieri Source : Feuille Potency : 20.0 % Bacosides A and B | 5.0 mg | Not calculated |
| 1,3,7-triméthylxanthine Source : Caféine | 65.0 mg | Not calculated |
| Piper nigrum Source : Piper nigrum - fruit Extraction ratio : 50:1 Dry plant equivalent : 87.5 mg Potency : 1.67 mg Piperine | 1.75 mg | Not calculated |
| L-Tyrosine Source : L-Tyrosine | 5.0 mg | Not calculated |
| Niacinamide Source : Niacinamide | 6.667 mg | Not calculated |
| Calcium Source : Carbonate de calcium | 50.0 mg | 300,000 µg |
| Vitamine D Source : Cholécalciférol Potency : 166.67 UI | 4.17 mcg | 25.02 µg |
| Extrait de fève de café vert Source : Coffea canephora - Graine Extraction ratio : 4:1 Dry plant equivalent : 266.67 mg Potency : 30.0 mg Chlorogenic acids | 66.67 mg | Not calculated |
| Extrait de fève de café vert Source : Coffea canephora - Graine Potency : 2.0 % Caffeine | Not specified | Not calculated |
| Rhodiola rosea Source : Rhodiola rosea - Racine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 283.3 mg Potency : 1.0 % Salidroside | 28.33 mg | Not calculated |
| Rhodiola rosea Source : Rhodiola rosea - Racine Potency : 3.0 % Rosavins | Not specified | Not calculated |
| Vitex agnus-castus Source : Vitex agnus-castus - Fruit Extract : Matériel brut sec Extraction ratio : 12:1 Dry plant equivalent : 80.04 mg | 6.67 mg | Not calculated |
| Curcuma longa Source : Curcuma longa - Racine | 5.0 mg | Not calculated |
| Punica granatum Source : Punica granatum, Fruit Extract : Matériel brut frais Extraction ratio : 12:1 Dry plant equivalent : 60 mg | 5.0 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Propylène glycol, Poly(éthylène glycol), Acide stéarique, Hydroxypropylcellulose, Acésulfame potassium, Dioxyde de titane, Croscarmellose de sodium, Stéarate de magnésium, Cellulose microcristalline, Hypromellose, Talc
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 3.0 Comprimé | 2.0 Tous les jours |
Uses authorised in Canada
Helps in the function of the thyroid gland. Helps the body to metabolize carbohydrates. Helps the body to metabolize proteins. Helps the body to metabolize fats. Helps normal growth and development. Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may help prevent bone loss/osteoporosis (in peri- and postmenopausal women) (in later life). Helps in the development and maintenance of bones and teeth. Helps in the absorption and use of calcium. Helps in the absorption and use of phosphorus. Calcium intake, when combined with sufficient Vitamin D, a healthy diet and regular exercise may reduce the risk of developing osteoporosis. Helps (temporarily) to promote alertness and wakefulness, and to enhance cognitive performance. Helps (temporarily) to relieve fatigue, to promote endurance, and to enhance motor performance. Used (temporarily) as a mild diuretic. Could be a complement to a healthy lifestyle that incorporates a calorie-reduced diet and regular physical activity for individuals involved in a weight management program. Provides antioxidants. (Used in Herbal Medicine) (as an adaptogen) (to) help(s) (to) temporary relieve symptoms of stress (such as mental fatigue and sensation of weakness). (Used in Herbal Medicine) (to) help(s) support cognitive function (such as mental focus and mental stamina). Used in Herbal Medicine to help relieve premenstrual symptoms. Used in Herbal Medicine as a hormone normaliser to help stabilise menstrual cycle irregularities. Used in Herbal Medicine to help relieve symptoms associated with menopause, such as hot flushes.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity/allergy is known to occur, in which case, discontinue use. If you experience irritability or insomnia, discontinue use. May cause digestive problems. Rare, unpredictable cases of liver injury associated with green tea extract-containing products have been reported (in Canada and internationally).
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are taking lithium. Consult a health care practitioner prior to use if you have high blood pressure, glaucoma, and/or detrusor instability (overactive bladder syndrome). Consumption with natural health products (e.g. bitter orange extract, synephrine, octopamine, ephedra) or other drugs (e.g. ephedrine) which increase blood pressure is not recommended. Consumption with other caffeine-containing products (e.g. medications, coffee, tea, colas, cocoa, guarana, maté) is not recommended. This product is not intended as a substitute for sleep. Consult a health care practitioner if you are of childbearing age, pregnant or breastfeeding. If you are breastfeeding, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you have an iron deficiency. Consult a health care practitioner if symptoms persist. Consult a health care practitioner if symptoms worsen. If you are taking any other medications or natural health products, consult a health care practitioner prior to use, as black pepper/piperine may alter their effectiveness. If you are taking hormone replacement therapy (HRT) or birth control pills, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you are taking hormone-containing medications such as progesterone preparations, oral contraceptives or hormone replacement therapy. If you are taking antidepressant medication, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you are following a low protein diet. Consult a health care practitioner prior to use if you have gallstones or a bile duct obstruction. Consult a health care practitioner prior to use if you have stomach ulcers or excess stomach acid. If you have a liver disorder, consult a health care practitioner prior to use. Stop use if you develop symptoms of liver trouble such as yellowing of the skin/eyes (jaundice), stomach pain, dark urine, sweating, nausea, unusual tiredness and/or loss of appetite and consult a health care practitioner.
- Contre-indications
If you are pregnant, do not use this product. If you have bipolar disorder or bipolar spectrum disorder, do not use this product.
Source
Official Health Canada record, licence 80065569
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.